So the FDA and pharmaceutical industry were really shy in investing in more obesity medications
The Fund may be susceptible to an increased risk of loss, including losses due to adverse events that affect the Funds investments more than the market as a whole, to the extent that the Funds investments are concentrated in the securities and/or other assets of a particular issuer or issuers, country, group of countries, region, market, industry, group of industries, sector, market segment or asset class
While zinc lacks inherent redox capacity, it is regarded as a powerful and crucial antioxidant agent
Either way, never start or stop any medications without consulting your healthcare provider first
IMPLICATIONS FOR TREATMENT The research underscores the importance of assessing weight history in addition to current weight in patients with eating disorders and shows that drugs that affect GLP-1 receptor agonists, initially approved by the FDA for type 2 diabetes and, more recently, for weight loss, could have potential applications in managing binge eating
Many patients notice smoother skin within 30 days
